Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-002806
Filing Date
2020-02-04
Accepted
2020-02-04 16:32:48
Documents
1
Period of Report
2020-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4021
  Complete submission text file 0000899243-20-002806.txt   5501
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Issuer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNLOGIC, INC. 301 BINNEY STREET, SUITE 402 CAMRIDGE MA 02142
Business Address
Burgess Michael F. (Reporting) CIK: 0001801745 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37566 | Film No.: 20574228